Vesicular neurotransmitter transport and the presynaptic regulation of quantal size

https://doi.org/10.1016/S0959-4388(98)80068-8Get rights and content

Abstract

Specific transport activities package classical neurotransmitters into secretory vesicles for release by regulated exocytosis, but the proteins responsible for the vesicular transport of neurotransmitters are still being identified. One family of proteins includes vesicular transporters for monoamines and acetylcholine. Genetic manipulation in cells and in mice now shows that changes in the expression of these proteins can alter the amount of neurotransmitter stored per synaptic vesicle, the amount released and behavior. Although the mechanisms responsible for regulating these transporters in vivo remains unknown, recent work has demonstrated the potential for regulation by changes in intrinsic activity and in location. In addition, a recently identified vesicular transporter for GABA defines a novel family of proteins that mediates the packaging of amino acid neurotransmitters.

References (44)

  • CidonS et al.

    ATP-dependent uptake of 5-hydroxytryptamine by secretory granules isolated from thyroid parafollicular cells

    J Biol Chem

    (1991)
  • NakanishiN et al.

    Effects of protein kinase inhibitors and protein phosphatase inhibitors on cyclic AMP-dependent down-regulation of vesicular monoamine transport in pheochromocytoma PC12 cells

    FEBS Lett

    (1995)
  • KalivasPW et al.

    Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya

    J Neurosci

    (1993)
  • NirenbergMJ et al.

    The vesicular monoamine transporter-2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei

    Proc Natl Acad Sci USA

    (1995)
  • BauerfeindR et al.

    Selective storge of acetylcholine, but not catecholamines, in neuroendocrine synaptic-like microvesicles of early endosomal origin

    Neuron

    (1993)
  • McIntireSL et al.

    Identification and characterization of the vesicular GABA transporter

    Nature

    (1997)
  • SagneC et al.

    Cloning of a functional vesicular GABA and glycine transporter by screening of genome databases

    FEBS Lett

    (1997)
  • OzkanED et al.

    A protein factor that inhibits ATP-dependent glutamate and γ-aminobutyric acid accumulation into synaptic vesicles: purification and initial characterization

    Proc Natl Acad Sci USA

    (1997)
  • SchuldinerS et al.

    Vesicular neurotransmitter transporters: from bacteria to humans

    Physiol Rev

    (1995)
  • LiuY et al.

    The role of vesicular transport proteins in synaptic transmission and neural degeneration

    Annu Rev Neurosci

    (1997)
  • KnothJ et al.

    Stoichiometry of H+-linked dopamine transport in chromaffin granule ghosts

    Biochemistry

    (1981)
  • LiuY et al.

    Gene transfer of a reserpine-sensitive mechanism of resistance to MPP+

    Proc Natl Acad Sci USA

    (1992)
  • Cited by (100)

    • VMAT2 Inhibitors and the Path to Ingrezza (Valbenazine)

      2018, Progress in Medicinal Chemistry
      Citation Excerpt :

      In the central nervous system, VMAT2 is predominantly located on small synaptic vesicles with a smaller portion localized to the dense-core vesicles [8–11]. Once VMAT2 is present on synaptic vesicles in the presynaptic terminal, it acts as a stoichiometric H+-ATPase antiporter utilizing an electrochemical gradient to drive transport [5,12]. The H+-ATPase utilizes ATP hydrolysis to generate the energy required to move H+ ions into the vesicle, creating an acidic (pH ~ 5.5) environment inside the vesicle [4].

    • Release of Neurotransmitters

      2014, From Molecules to Networks: An Introduction to Cellular and Molecular Neuroscience: Third Edition
    View all citing articles on Scopus
    View full text